Istituzioni

The FDA announced the availability of educational resources for parents and caregivers with questions about using the hundreds of millions of bottles worth of imported infant formula headed to the U.S.

The FDA issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.

Today, the FDA issued warning letters to four companies for illegally selling honey-based products that may pose a significant health risk to consumers.

FDA Infant Formula Update: July 8 (Australia)

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA is developing a new framework for continue and expanded access to infant formula options for U.S. parents and caregivers.

The FDA revised the EUA for Paxlovid to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid

FDA Infant Formula Update July 6 Vitaflo (Netherlands)

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Infant Formula Update June 30 Danone New Zealand

The FDA has advised manufacturers seeking to update their COVID-19 vaccines that they should develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a two component (bivalent) booster vaccine, beginning in Fall 2022.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Infant Formula Update June 28 Abbott (Ireland)

Today, the FDA issued a proposal to broaden the range of marketed nonprescription drugs available to consumers.

FDA Infant Formula Update June 27 Bellamy (Australia)

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA launched the Action Plan for Rare Neurodegenerative Diseases including ALS, outlining the agency’s strategy for improving and extending the lives of people living with these diseases by advancing the development of safe, effective medical products, and by facilitating patient access to novel

Today, the U.S. Food and Drug Administration issued marketing denial orders (MDOs) to JUUL Labs Inc. for all of their products currently marketed in the United States. As a result, the company must stop selling and distributing these products.

FDA exercises enforcement discretion to Global Kosher to import various Kendamil infant formula products from United Kingdom following review of nutritional adequacy and safety information, including microbiological testing, labeling, facility production and inspection history